$INFU
InfuSystem Holdings, Inc

2014 Q2 Form 10-Q Financial Statement

#000119312514290576 Filed on August 01, 2014

View on sec.gov

Income Statement

Concept 2014 Q2 2013 Q2
Revenue $16.37M $14.66M
YoY Change 11.66% 4.19%
Cost Of Revenue $2.913M $2.845M
YoY Change 2.39% 32.45%
Gross Profit $11.92M $10.33M
YoY Change 15.42% 0.55%
Gross Profit Margin 72.83% 70.45%
Selling, General & Admin $7.522M $7.490M
YoY Change 0.43% -13.69%
% of Gross Profit 63.09% 72.51%
Research & Development
YoY Change
% of Gross Profit
Depreciation & Amortization $100.0K $100.0K
YoY Change 0.0% 0.0%
% of Gross Profit 0.84% 0.97%
Operating Expenses $9.585M $9.469M
YoY Change 1.23% -7.57%
Operating Profit $2.338M $861.0K
YoY Change 171.54% 2868.97%
Interest Expense $776.0K $924.0K
YoY Change -16.02% 39.37%
% of Operating Profit 33.19% 107.32%
Other Income/Expense, Net -$736.0K -$900.0K
YoY Change -18.22% -25.93%
Pretax Income $1.602M -$39.00K
YoY Change -4207.69% -96.71%
Income Tax $716.0K -$144.0K
% Of Pretax Income 44.69%
Net Earnings $886.0K $105.0K
YoY Change 743.81% -112.68%
Net Earnings / Revenue 5.41% 0.72%
Basic Earnings Per Share $0.04 $0.00
Diluted Earnings Per Share $0.04 $0.00
COMMON SHARES
Basic Shares Outstanding 22.15M shares 21.86M shares
Diluted Shares Outstanding 22.40M shares 22.02M shares

Balance Sheet

Concept 2014 Q2 2013 Q2
SHORT-TERM ASSETS
Cash & Short-Term Investments $1.000M $100.0K
YoY Change 900.0% -87.5%
Cash & Equivalents $1.041M $102.0K
Short-Term Investments
Other Short-Term Assets $712.0K $713.0K
YoY Change -0.14% -49.07%
Inventory $1.485M $1.379M
Prepaid Expenses
Receivables $10.77M $9.440M
Other Receivables $0.00 $0.00
Total Short-Term Assets $16.30M $13.62M
YoY Change 19.69% -1.3%
LONG-TERM ASSETS
Property, Plant & Equipment $1.577M $798.0K
YoY Change 97.62% -94.46%
Goodwill
YoY Change
Intangibles $24.29M $24.22M
YoY Change 0.27%
Long-Term Investments
YoY Change
Other Assets $248.0K $157.0K
YoY Change 57.96% -99.19%
Total Long-Term Assets $61.43M $62.13M
YoY Change -1.12% 2.02%
TOTAL ASSETS
Total Short-Term Assets $16.30M $13.62M
Total Long-Term Assets $61.43M $62.13M
Total Assets $77.74M $75.75M
YoY Change 2.62% 1.41%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable $4.101M $3.833M
YoY Change 6.99% -20.15%
Accrued Expenses
YoY Change
Deferred Revenue
YoY Change
Short-Term Debt $0.00 $0.00
YoY Change
Long-Term Debt Due $3.871M $3.124M
YoY Change 23.91% -50.41%
Total Short-Term Liabilities $10.55M $9.739M
YoY Change 8.28% -30.44%
LONG-TERM LIABILITIES
Long-Term Debt $22.83M $25.20M
YoY Change -9.42% 17.23%
Other Long-Term Liabilities
YoY Change
Total Long-Term Liabilities $22.83M $25.20M
YoY Change -9.42% 17.23%
TOTAL LIABILITIES
Total Short-Term Liabilities $10.55M $9.739M
Total Long-Term Liabilities $22.83M $25.20M
Total Liabilities $33.37M $34.94M
YoY Change -4.49% -1.57%
SHAREHOLDERS EQUITY
Retained Earnings -$45.59M -$48.58M
YoY Change -6.14%
Common Stock $2.000K $2.000K
YoY Change 0.0%
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity $44.36M $40.81M
YoY Change
Total Liabilities & Shareholders Equity $77.74M $75.75M
YoY Change 2.62% 1.41%

Cashflow Statement

Concept 2014 Q2 2013 Q2
OPERATING ACTIVITIES
Net Income $886.0K $105.0K
YoY Change 743.81% -112.68%
Depreciation, Depletion And Amortization $100.0K $100.0K
YoY Change 0.0% 0.0%
Cash From Operating Activities $2.450M $600.0K
YoY Change 308.33% -83.7%
INVESTING ACTIVITIES
Capital Expenditures $500.0K -$780.0K
YoY Change -164.1% -310.81%
Acquisitions
YoY Change
Other Investing Activities $2.760M $640.0K
YoY Change 331.25% -163.37%
Cash From Investing Activities -$650.0K -$160.0K
YoY Change 306.25% -75.0%
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net
YoY Change
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities -1.250M -820.0K
YoY Change 52.44% -63.39%
NET CHANGE
Cash From Operating Activities 2.450M 600.0K
Cash From Investing Activities -650.0K -160.0K
Cash From Financing Activities -1.250M -820.0K
Net Change In Cash 550.0K -380.0K
YoY Change -244.74% -147.5%
FREE CASH FLOW
Cash From Operating Activities $2.450M $600.0K
Capital Expenditures $500.0K -$780.0K
Free Cash Flow $1.950M $1.380M
YoY Change 41.3% -58.31%

Facts In Submission

Frame Concept Type Concept / XBRL Key Value Unit
CY2014Q2 us-gaap Long Term Debt Maturities Repayments Of Principal In Year Four
LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFour
149000
CY2014Q2 us-gaap Long Term Debt Noncurrent
LongTermDebtNoncurrent
22829000
CY2014Q2 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
77735000
CY2014Q2 us-gaap Additional Paid In Capital
AdditionalPaidInCapital
89951000
CY2014Q3 dei Entity Common Stock Shares Outstanding
EntityCommonStockSharesOutstanding
22397043 shares
CY2013Q2 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
102000
CY2014Q2 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
22400743 shares
CY2014Q2 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
22203053 shares
CY2014Q2 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
200000000 shares
CY2014Q2 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.0001
CY2014Q2 us-gaap Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
1000000 shares
CY2014Q2 us-gaap Preferred Stock Par Or Stated Value Per Share
PreferredStockParOrStatedValuePerShare
0.0001
CY2014Q2 us-gaap Preferred Stock Shares Issued
PreferredStockSharesIssued
0 shares
CY2014Q2 us-gaap Other Liabilities Current
OtherLiabilitiesCurrent
2573000
CY2014Q2 us-gaap Preferred Stock Value
PreferredStockValue
0
CY2014Q2 us-gaap Long Term Debt Maturities Repayments Of Principal In Year Three
LongTermDebtMaturitiesRepaymentsOfPrincipalInYearThree
20765000
CY2014Q2 us-gaap Liabilities Current
LiabilitiesCurrent
10545000
CY2014Q2 us-gaap Common Stock Value
CommonStockValue
2000
CY2014Q2 us-gaap Accounts Payable Current
AccountsPayableCurrent
4101000
CY2014Q2 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-45592000
CY2014Q2 us-gaap Long Term Debt Current
LongTermDebtCurrent
3871000
CY2014Q2 us-gaap Stockholders Equity
StockholdersEquity
44361000
CY2014Q2 us-gaap Long Term Debt Maturities Repayments Of Principal Remainder Of Fiscal Year
LongTermDebtMaturitiesRepaymentsOfPrincipalRemainderOfFiscalYear
1912000
CY2014Q2 us-gaap Liabilities
Liabilities
33374000
CY2014Q2 us-gaap Long Term Debt Maturities Repayments Of Principal In Year Two
LongTermDebtMaturitiesRepaymentsOfPrincipalInYearTwo
3874000
CY2014Q2 us-gaap Long Term Debt
LongTermDebt
26700000
CY2014Q2 us-gaap Allowance For Doubtful Accounts Receivable Current
AllowanceForDoubtfulAccountsReceivableCurrent
5574000
CY2014Q2 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
1041000
CY2014Q2 us-gaap Finite Lived Intangible Assets Amortization Expense Year Four
FiniteLivedIntangibleAssetsAmortizationExpenseYearFour
2201000
CY2014Q2 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
1577000
CY2014Q2 us-gaap Intangible Assets Gross Excluding Goodwill
IntangibleAssetsGrossExcludingGoodwill
39982000
CY2014Q2 us-gaap Deferred Tax Assets Net Noncurrent
DeferredTaxAssetsNetNoncurrent
15376000
CY2014Q2 us-gaap Finite Lived Intangible Assets Amortization Expense Year Five
FiniteLivedIntangibleAssetsAmortizationExpenseYearFive
2191000
CY2014Q2 us-gaap Deferred Finance Costs Noncurrent Net
DeferredFinanceCostsNoncurrentNet
1505000
CY2014Q2 us-gaap Finite Lived Intangible Assets Amortization Expense After Year Five
FiniteLivedIntangibleAssetsAmortizationExpenseAfterYearFive
12096000
CY2014Q2 us-gaap Assets
Assets
77735000
CY2014Q2 us-gaap Deferred Tax Assets Net Current
DeferredTaxAssetsNetCurrent
2296000
CY2014Q2 us-gaap Finite Lived Intangible Assets Amortization Expense Year Two
FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo
2321000
CY2014Q2 us-gaap Inventory Net
InventoryNet
1485000
CY2014Q2 us-gaap Accounts Receivable Net Current
AccountsReceivableNetCurrent
10768000
CY2014Q2 us-gaap Intangible Assets Net Excluding Goodwill
IntangibleAssetsNetExcludingGoodwill
24287000
CY2014Q2 us-gaap Other Assets Current
OtherAssetsCurrent
712000
CY2014Q2 us-gaap Other Assets Noncurrent
OtherAssetsNoncurrent
248000
CY2014Q2 us-gaap Assets Current
AssetsCurrent
16302000
CY2014Q2 us-gaap Finite Lived Intangible Assets Amortization Expense Remainder Of Fiscal Year
FiniteLivedIntangibleAssetsAmortizationExpenseRemainderOfFiscalYear
1243000
CY2014Q2 us-gaap Finite Lived Intangible Assets Amortization Expense Year Three
FiniteLivedIntangibleAssetsAmortizationExpenseYearThree
2235000
CY2014Q2 infu Medical Equipment Held For Sale Or Rental
MedicalEquipmentHeldForSaleOrRental
2255000
CY2014Q2 infu Medical Equipment In Rental Services Gross
MedicalEquipmentInRentalServicesGross
39460000
CY2014Q2 infu Medical Equipment In Rental Services Accumulated Depreciation
MedicalEquipmentInRentalServicesAccumulatedDepreciation
23156000
CY2014Q2 infu Medical Equipment Net
MedicalEquipmentNet
18440000
CY2014Q2 infu Medical Equipment In Rental Services Reserve
MedicalEquipmentInRentalServicesReserve
119000
CY2014Q2 infu Intangible Assets Accumulated Amortization
IntangibleAssetsAccumulatedAmortization
15695000
CY2014Q2 infu Medical Equipment In Rental Service Net Of Accumulated Depreciation
MedicalEquipmentInRentalServiceNetOfAccumulatedDepreciation
16185000
CY2012Q4 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
2326000
CY2013Q4 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
22158041 shares
CY2013Q4 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
21960351 shares
CY2013Q4 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
200000000 shares
CY2013Q4 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.0001
CY2013Q4 us-gaap Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
1000000 shares
CY2013Q4 us-gaap Preferred Stock Par Or Stated Value Per Share
PreferredStockParOrStatedValuePerShare
0.0001
CY2013Q4 us-gaap Preferred Stock Shares Issued
PreferredStockSharesIssued
0 shares
CY2013Q4 us-gaap Other Liabilities Current
OtherLiabilitiesCurrent
3187000
CY2013Q4 us-gaap Preferred Stock Value
PreferredStockValue
0
CY2013Q4 us-gaap Liabilities Current
LiabilitiesCurrent
13041000
CY2013Q4 us-gaap Common Stock Value
CommonStockValue
2000
CY2013Q4 us-gaap Accounts Payable Current
AccountsPayableCurrent
4736000
CY2013Q4 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-47062000
CY2013Q4 us-gaap Long Term Debt Current
LongTermDebtCurrent
5118000
CY2013Q4 us-gaap Stockholders Equity
StockholdersEquity
42723000
CY2013Q4 us-gaap Long Term Debt Noncurrent
LongTermDebtNoncurrent
21609000
CY2013Q4 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
77373000
CY2013Q2 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
22015499 shares
CY2013Q4 infu Medical Equipment In Rental Service Net Of Accumulated Depreciation
MedicalEquipmentInRentalServiceNetOfAccumulatedDepreciation
14438000
us-gaap Gross Profit
GrossProfit
20753000
us-gaap Sales Revenue Goods Net
SalesRevenueGoodsNet
2302000
us-gaap Repayments Of Long Term Capital Lease Obligations
RepaymentsOfLongTermCapitalLeaseObligations
16918000
CY2013Q4 infu Medical Equipment In Rental Services Gross
MedicalEquipmentInRentalServicesGross
37252000
CY2013Q4 infu Medical Equipment In Rental Services Accumulated Depreciation
MedicalEquipmentInRentalServicesAccumulatedDepreciation
22727000
CY2013Q4 infu Medical Equipment Net
MedicalEquipmentNet
18102000
CY2013Q4 infu Medical Equipment In Rental Services Reserve
MedicalEquipmentInRentalServicesReserve
87000
CY2013Q4 infu Intangible Assets Accumulated Amortization
IntangibleAssetsAccumulatedAmortization
14438000
CY2013Q4 us-gaap Additional Paid In Capital
AdditionalPaidInCapital
89783000
CY2013Q4 us-gaap Liabilities
Liabilities
34650000
CY2013Q4 us-gaap Long Term Debt
LongTermDebt
26727000
CY2013Q4 us-gaap Allowance For Doubtful Accounts Receivable Current
AllowanceForDoubtfulAccountsReceivableCurrent
4774000
CY2013Q4 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
1138000
CY2013Q4 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
872000
CY2013Q4 us-gaap Intangible Assets Gross Excluding Goodwill
IntangibleAssetsGrossExcludingGoodwill
38620000
CY2013Q4 us-gaap Deferred Tax Assets Net Noncurrent
DeferredTaxAssetsNetNoncurrent
16300000
CY2013Q4 us-gaap Deferred Finance Costs Noncurrent Net
DeferredFinanceCostsNoncurrentNet
1817000
CY2013Q4 us-gaap Assets
Assets
77373000
CY2013Q4 us-gaap Deferred Tax Assets Net Current
DeferredTaxAssetsNetCurrent
2296000
CY2013Q4 us-gaap Inventory Net
InventoryNet
1234000
CY2013Q4 us-gaap Accounts Receivable Net Current
AccountsReceivableNetCurrent
10697000
CY2013Q4 us-gaap Intangible Assets Net Excluding Goodwill
IntangibleAssetsNetExcludingGoodwill
24182000
CY2013Q4 us-gaap Other Assets Current
OtherAssetsCurrent
518000
CY2013Q4 us-gaap Other Assets Noncurrent
OtherAssetsNoncurrent
217000
CY2013Q4 us-gaap Assets Current
AssetsCurrent
15883000
CY2013Q4 infu Medical Equipment Held For Sale Or Rental
MedicalEquipmentHeldForSaleOrRental
3664000
CY2014Q2 infu Debt Instrument Effective Floating And Fixed Interest Rate Increase Decrease
DebtInstrumentEffectiveFloatingAndFixedInterestRateIncreaseDecrease
-0.015 pure
CY2014Q2 us-gaap Repayments Of Lines Of Credit
RepaymentsOfLinesOfCredit
1600000
CY2014Q2 us-gaap Debt Instrument Basis Spread On Variable Rate1
DebtInstrumentBasisSpreadOnVariableRate1
0.0775 pure
us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
0.01
us-gaap Incremental Common Shares Attributable To Share Based Payment Arrangements
IncrementalCommonSharesAttributableToShareBasedPaymentArrangements
220299 shares
us-gaap Net Cash Provided By Used In Operating Activities Continuing Operations
NetCashProvidedByUsedInOperatingActivitiesContinuingOperations
2233000
us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
22052151 shares
us-gaap Earnings Per Share Basic
EarningsPerShareBasic
0.01
us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
21831852 shares
us-gaap Payments To Acquire Productive Assets
PaymentsToAcquireProductiveAssets
2564000
us-gaap Sales Revenue Net
SalesRevenueNet
29363000
us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
51000
us-gaap Operating Income Loss
OperatingIncomeLoss
1513000
us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
156000
us-gaap Operating Leases Income Statement Lease Revenue
OperatingLeasesIncomeStatementLeaseRevenue
27061000
us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
-1462000
us-gaap Payments For Repurchase Of Common Stock
PaymentsForRepurchaseOfCommonStock
41000
us-gaap Net Cash Provided By Used In Investing Activities Continuing Operations
NetCashProvidedByUsedInInvestingActivitiesContinuingOperations
-838000
us-gaap Proceeds From Sale Of Productive Assets
ProceedsFromSaleOfProductiveAssets
1726000
us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
10039000
us-gaap Proceeds From Repayments Of Debt
ProceedsFromRepaymentsOfDebt
13340000
infu Depreciation Expense Related To Medical Equipment
DepreciationExpenseRelatedToMedicalEquipment
2400000
infu Cost Of Revenues Pump Depreciation Sales And Disposals
CostOfRevenuesPumpDepreciationSalesAndDisposals
3186000
us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
336000
us-gaap Net Income Loss
NetIncomeLoss
156000
us-gaap Interest Expense
InterestExpense
1798000
us-gaap Operating Expenses
OperatingExpenses
19240000
us-gaap Selling And Marketing Expense
SellingAndMarketingExpense
4890000
us-gaap Cost Of Goods And Services Sold
CostOfGoodsAndServicesSold
5424000
us-gaap Provision For Doubtful Accounts
ProvisionForDoubtfulAccounts
2987000
us-gaap Amortization Of Intangible Assets
AmortizationOfIntangibleAssets
1324000
us-gaap Cash And Cash Equivalents Period Increase Decrease
CashAndCashEquivalentsPeriodIncreaseDecrease
-2224000
us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
-105000
us-gaap Depreciation
Depreciation
200000
us-gaap Net Cash Provided By Used In Financing Activities Continuing Operations
NetCashProvidedByUsedInFinancingActivitiesContinuingOperations
-3619000
us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
0.07
dei Document Type
DocumentType
10-Q
dei Entity Registrant Name
EntityRegistrantName
InfuSystem Holdings, Inc
dei Trading Symbol
TradingSymbol
INFU
dei Entity Filer Category
EntityFilerCategory
Smaller Reporting Company
us-gaap Effective Income Tax Rate Continuing Operations
EffectiveIncomeTaxRateContinuingOperations
0.421 pure
us-gaap Incremental Common Shares Attributable To Share Based Payment Arrangements
IncrementalCommonSharesAttributableToShareBasedPaymentArrangements
261241 shares
us-gaap Net Cash Provided By Used In Operating Activities Continuing Operations
NetCashProvidedByUsedInOperatingActivitiesContinuingOperations
1806000
us-gaap Debt Instrument Description Of Variable Rate Basis
DebtInstrumentDescriptionOfVariableRateBasis
LIBOR plus 7.25% (with a LIBOR floor of 2.0%) or the Wells Fargo prime rate plus 6.25% (with a prime rate floor of 3.0%).
us-gaap Line Of Credit Facility Expiration Date1
LineOfCreditFacilityExpirationDate1
2016-11-30
dei Document Period End Date
DocumentPeriodEndDate
2014-06-30
dei Amendment Flag
AmendmentFlag
false
dei Current Fiscal Year End Date
CurrentFiscalYearEndDate
--12-31
dei Document Fiscal Year Focus
DocumentFiscalYearFocus
2014
us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
22321143 shares
us-gaap Earnings Per Share Basic
EarningsPerShareBasic
0.07
us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
-1580000
us-gaap Payments For Repurchase Of Common Stock
PaymentsForRepurchaseOfCommonStock
103000
us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
23000
us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
2534000
us-gaap Operating Income Loss
OperatingIncomeLoss
4114000
us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
1469000
us-gaap Operating Leases Income Statement Lease Revenue
OperatingLeasesIncomeStatementLeaseRevenue
29645000
dei Entity Central Index Key
EntityCentralIndexKey
0001337013
dei Document Fiscal Period Focus
DocumentFiscalPeriodFocus
Q2
us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
22059902 shares
us-gaap Gross Profit
GrossProfit
23999000
us-gaap Sales Revenue Goods Net
SalesRevenueGoodsNet
3969000
us-gaap Repayments Of Long Term Capital Lease Obligations
RepaymentsOfLongTermCapitalLeaseObligations
33479000
us-gaap Payments To Acquire Productive Assets
PaymentsToAcquireProductiveAssets
4524000
us-gaap Sales Revenue Net
SalesRevenueNet
33614000
CY2014Q2 us-gaap Provision For Doubtful Accounts
ProvisionForDoubtfulAccounts
1438000
CY2014Q2 us-gaap Amortization Of Intangible Assets
AmortizationOfIntangibleAssets
625000
CY2014Q2 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
716000
us-gaap Net Income Loss
NetIncomeLoss
1469000
us-gaap Interest Expense
InterestExpense
1603000
us-gaap Operating Expenses
OperatingExpenses
19885000
us-gaap Selling And Marketing Expense
SellingAndMarketingExpense
5279000
us-gaap Cost Of Goods And Services Sold
CostOfGoodsAndServicesSold
5803000
us-gaap Provision For Doubtful Accounts
ProvisionForDoubtfulAccounts
3545000
us-gaap Amortization Of Intangible Assets
AmortizationOfIntangibleAssets
1254000
us-gaap Cash And Cash Equivalents Period Increase Decrease
CashAndCashEquivalentsPeriodIncreaseDecrease
-97000
us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
1065000
us-gaap Depreciation
Depreciation
200000
us-gaap Net Cash Provided By Used In Financing Activities Continuing Operations
NetCashProvidedByUsedInFinancingActivitiesContinuingOperations
-1384000
us-gaap Net Cash Provided By Used In Investing Activities Continuing Operations
NetCashProvidedByUsedInInvestingActivitiesContinuingOperations
-519000
us-gaap Proceeds From Sale Of Productive Assets
ProceedsFromSaleOfProductiveAssets
4005000
us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
9807000
us-gaap Proceeds From Repayments Of Debt
ProceedsFromRepaymentsOfDebt
32198000
infu Depreciation Expense Related To Medical Equipment
DepreciationExpenseRelatedToMedicalEquipment
1500000
infu Effect Of Change In Accounting Estimate On Estimated Useful Life Of Assets
EffectOfChangeInAccountingEstimateOnEstimatedUsefulLifeOfAssets
1000000
infu Effect Of Change In Accounting Estimate On Estimated Useful Life Of Assets Earnings Per Share Basic And Diluted
EffectOfChangeInAccountingEstimateOnEstimatedUsefulLifeOfAssetsEarningsPerShareBasicAndDiluted
0
infu Effect Of Change In Accounting Estimate On Estimated Useful Life Of Assets Increase Decrease Net Income
EffectOfChangeInAccountingEstimateOnEstimatedUsefulLifeOfAssetsIncreaseDecreaseNetIncome
600000
infu Cost Of Revenues Pump Depreciation Sales And Disposals
CostOfRevenuesPumpDepreciationSalesAndDisposals
3812000
CY2014Q2 us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
500000
CY2013 us-gaap Property Plant And Equipment Useful Life
PropertyPlantAndEquipmentUsefulLife
P5Y
CY2014Q1 us-gaap Property Plant And Equipment Useful Life
PropertyPlantAndEquipmentUsefulLife
P7Y
CY2013Q2 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
0.00
CY2013Q2 us-gaap Effective Income Tax Rate Continuing Operations
EffectiveIncomeTaxRateContinuingOperations
0.382 pure
CY2013Q2 us-gaap Incremental Common Shares Attributable To Share Based Payment Arrangements
IncrementalCommonSharesAttributableToShareBasedPaymentArrangements
154633 shares
CY2013Q2 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
0.00
CY2013Q2 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
21860866 shares
CY2013Q2 us-gaap Gross Profit
GrossProfit
10330000
CY2013Q2 us-gaap Sales Revenue Goods Net
SalesRevenueGoodsNet
1044000
CY2013Q2 us-gaap Sales Revenue Net
SalesRevenueNet
14662000
CY2013Q2 us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
-39000
CY2013Q2 us-gaap Operating Income Loss
OperatingIncomeLoss
861000
CY2013Q2 us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
105000
CY2013Q2 us-gaap Operating Leases Income Statement Lease Revenue
OperatingLeasesIncomeStatementLeaseRevenue
13618000
CY2013Q2 us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
-900000
CY2013Q2 us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
24000
CY2013Q2 us-gaap Net Income Loss
NetIncomeLoss
105000
CY2013Q2 us-gaap Interest Expense
InterestExpense
924000
CY2013Q2 us-gaap Operating Expenses
OperatingExpenses
9469000
CY2013Q2 us-gaap Selling And Marketing Expense
SellingAndMarketingExpense
2482000
CY2013Q2 us-gaap Cost Of Goods And Services Sold
CostOfGoodsAndServicesSold
2845000
CY2013Q2 us-gaap Provision For Doubtful Accounts
ProvisionForDoubtfulAccounts
1327000
CY2013Q2 us-gaap Amortization Of Intangible Assets
AmortizationOfIntangibleAssets
652000
CY2013Q2 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
-144000
CY2013Q2 us-gaap Depreciation
Depreciation
100000
CY2013Q2 us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
5008000
CY2013Q2 infu Depreciation Expense Related To Medical Equipment
DepreciationExpenseRelatedToMedicalEquipment
1300000
CY2013Q2 infu Cost Of Revenues Pump Depreciation Sales And Disposals
CostOfRevenuesPumpDepreciationSalesAndDisposals
1487000
CY2014Q2 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
0.04
CY2014Q2 us-gaap Effective Income Tax Rate Continuing Operations
EffectiveIncomeTaxRateContinuingOperations
0.413 pure
CY2014Q2 us-gaap Incremental Common Shares Attributable To Share Based Payment Arrangements
IncrementalCommonSharesAttributableToShareBasedPaymentArrangements
253328 shares
CY2014Q2 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
22399434 shares
CY2014Q2 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
0.04
CY2014Q2 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
22146106 shares
CY2014Q2 us-gaap Gross Profit
GrossProfit
11923000
CY2014Q2 us-gaap Sales Revenue Goods Net
SalesRevenueGoodsNet
1577000
CY2014Q2 us-gaap Sales Revenue Net
SalesRevenueNet
16372000
CY2014Q2 us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
1602000
CY2014Q2 us-gaap Operating Income Loss
OperatingIncomeLoss
2338000
CY2014Q2 us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
886000
CY2014Q2 us-gaap Operating Leases Income Statement Lease Revenue
OperatingLeasesIncomeStatementLeaseRevenue
14795000
CY2014Q2 us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
-736000
CY2014Q2 us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
40000
CY2014Q2 us-gaap Net Income Loss
NetIncomeLoss
886000
CY2014Q2 us-gaap Interest Expense
InterestExpense
776000
CY2014Q2 us-gaap Operating Expenses
OperatingExpenses
9585000
CY2014Q2 us-gaap Selling And Marketing Expense
SellingAndMarketingExpense
2624000
CY2014Q2 us-gaap Cost Of Goods And Services Sold
CostOfGoodsAndServicesSold
2913000
CY2014Q2 us-gaap Depreciation
Depreciation
100000
CY2014Q2 us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
4898000
CY2014Q2 infu Depreciation Expense Related To Medical Equipment
DepreciationExpenseRelatedToMedicalEquipment
800000
CY2014Q2 infu Effect Of Change In Accounting Estimate On Estimated Useful Life Of Assets
EffectOfChangeInAccountingEstimateOnEstimatedUsefulLifeOfAssets
500000
CY2014Q2 infu Effect Of Change In Accounting Estimate On Estimated Useful Life Of Assets Increase Decrease Net Income
EffectOfChangeInAccountingEstimateOnEstimatedUsefulLifeOfAssetsIncreaseDecreaseNetIncome
300000
CY2014Q2 infu Cost Of Revenues Pump Depreciation Sales And Disposals
CostOfRevenuesPumpDepreciationSalesAndDisposals
1536000

Files In Submission

Name View Source Status
0001193125-14-290576-index-headers.html Edgar Link pending
0001193125-14-290576-index.html Edgar Link pending
0001193125-14-290576.txt Edgar Link pending
0001193125-14-290576-xbrl.zip Edgar Link pending
d753025d10q.htm Edgar Link pending
d753025dex102.htm Edgar Link pending
d753025dex311.htm Edgar Link pending
d753025dex312.htm Edgar Link pending
d753025dex321.htm Edgar Link pending
d753025dex322.htm Edgar Link pending
FilingSummary.xml Edgar Link unprocessable
Financial_Report.xls Edgar Link pending
Financial_Report.xlsx Edgar Link pending
g753025g80p73.jpg Edgar Link pending
infu-20140630.xml Edgar Link completed
infu-20140630.xsd Edgar Link pending
infu-20140630_cal.xml Edgar Link unprocessable
infu-20140630_def.xml Edgar Link unprocessable
infu-20140630_lab.xml Edgar Link unprocessable
infu-20140630_pre.xml Edgar Link unprocessable
R1.htm Edgar Link pending
R10.htm Edgar Link pending
R11.htm Edgar Link pending
R12.htm Edgar Link pending
R13.htm Edgar Link pending
R14.htm Edgar Link pending
R15.htm Edgar Link pending
R16.htm Edgar Link pending
R17.htm Edgar Link pending
R18.htm Edgar Link pending
R19.htm Edgar Link pending
R2.htm Edgar Link pending
R20.htm Edgar Link pending
R21.htm Edgar Link pending
R22.htm Edgar Link pending
R23.htm Edgar Link pending
R24.htm Edgar Link pending
R25.htm Edgar Link pending
R26.htm Edgar Link pending
R27.htm Edgar Link pending
R28.htm Edgar Link pending
R29.htm Edgar Link pending
R3.htm Edgar Link pending
R30.htm Edgar Link pending
R31.htm Edgar Link pending
R32.htm Edgar Link pending
R4.htm Edgar Link pending
R5.htm Edgar Link pending
R6.htm Edgar Link pending
R7.htm Edgar Link pending
R8.htm Edgar Link pending
R9.htm Edgar Link pending
report.css Edgar Link pending
Show.js Edgar Link pending